I'm Less Positive On H.B. Fuller After This Quarter (Downgrade)

Grassroots Trading2.81K FollowersFollow5ShareSavePlay(11min)CommentsSummaryWith margins holding up but sales volumes weakening, the stock’s upside appears limited, leading to a neutral stance on shares.Organic revenue declined 6.6%, driven primarily by a 7.2% drop in sales volumes across several end markets.Customer caution in construction and general industrial markets continued to weigh on demand, particularly within Building Adhesive Solutions and consumer-related segments.Net leverage has improved to roughly 3.1× EBITDA, though the company still carries a relatively high debt load and a below-investment-grade credit rating. Martin Barraud/OJO Images via Getty Images Thesis This is the third time I’ve written about H.B. Fuller Company (FUL), which is a global company that makes adhesives used in many industries, including packaging, hygiene products, electronics, and construction. In my most recent analysis, This article was written byGrassroots Trading2.81K FollowersFollowI focus on producing objective, data-driven research, mostly about small- to mid-cap companies, as these tend to be overlooked by many investors. From time to time, though, I also look at large-cap names, just to give a fuller sense of the broader equity markets.Analyst’s Disclosure: I/we have a beneficial long position in the shares of FUL either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.